Yearly Archives: 2022

The Department of Health and Social Care (DHSC) has today (22/07/2022) granted the following list of price concessions: Drug Pack size Price concession Celecoxib 200mg capsules 30 £5.97 Clarithromycin 250mg/5ml oral suspension 70 £5.00 Clotrimazole 500mg pessaries 1 £5.20 Cyclizine 50mg/1ml solution for injection ampoules 5 £6.16 Desloratadine 5mg tablets 30 £4.91 Flucloxacillin 500mg capsules [...]

The post July 2022 Price Concessions 2nd Update appeared first on PSNC Website.

PSNC has agreed to take forward a comprehensive new programme of work to address the 21 RSG proposals that were directed at the Committee. Alongside that, the Committee has reaffirmed its commitment to supporting LPCs through the proposed changes for them, and to working together with LPCs on the 10 joint PSNC and LPC proposals. [...]

The post PSNC launches Transforming Pharmacy Representation (TAPR) Programme    appeared first on PSNC Website.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 15 Issue 12 July 2022) has been published and includes articles on: Topiramate (Topamax): start of safety review triggered by a study reporting an increased risk of neurodevelopmental disabilities in children with prenatal exposure COVID-19 vaccines and medicines: updates for July 2022 [...]

The post MHRA Drug Safety Update July 2022 appeared first on PSNC Website.

Class 4 Medicines Defect Information: NovoRapid® FlexTouch® 100 units/ml and Saxenda® FlexTouch® (liraglutide) 6mg/ml (Novo Nordisk Limited) Drug alert number: EL (22)A/33 Date issued: 21 July 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Novorapid FlexTouch 100units/ml solution for injection in pre-filled pen (insulin [...]

The post MHRA Class 4 Medicines Defect Information: NovoRapid FlexTouch 100units/ml and Saxenda FlexTouch 6mg/ml appeared first on PSNC Website.